BioMed Research International

Alternatives to Transplantation in the Treatment of Heart Failure: New Diagnostic and Therapeutic Insights


Status
Published

1University of Parma, Parma, Italy

2Guglielmo da Saliceto Polichirurgico Hospital, Piacenza, Italy

3University of Bologna, Bologna, Italy

4University Hospital Lausanne, Lausanne, Switzerland


Alternatives to Transplantation in the Treatment of Heart Failure: New Diagnostic and Therapeutic Insights

Description

Cardiovascular disease is the leading cause of mortality in the USA and Western countries with ischemic heart disease accounting for the majority of these deaths. Paradoxically, the improvements in the medical and surgical treatment of acute coronary syndromes are leading to an increasing number of “survivors” who are then developing heart failure. Despite the considerable advances in the management of heart failure, the gold standard for the treatment of end-stage heart failure patients remains heart transplantation. Nevertheless, this procedure can be offered only to a small percentage of patients who could benefit from a new heart, due to the limited availability of donor organs. In fact, the number of heart transplants has remained static worldwide and the number of heart transplants performed each year in the United States has plateaued at about 2100 for the past few years. Improving awareness of the very end stages of heart failure is emerging as a major need for the clinical community, and implementing best practices for alternative care is also growing.

A number of innovative approaches are being investigated in terms of improved survival and quality of life in patient’s refractory to medical therapy and excluded from cardiac transplantation lists. These procedures include the optimization of medical therapy, coronary artery bypass surgery, and valve surgery in high risk patients, ventricular restoration techniques, and the implantation of ventricular assist devices as destination therapy or other approaches (such as cardiac resynchronization therapy). Future therapies for heart failure could include new approaches with stem cell therapy, associated with standard revascularization techniques or with other procedures such as the implantation of innovative ventricular assist devices, new ventricular restoration techniques, or new drugs.

Of interest, a significant proportion of patients present with an idiopathic cardiomyopathy; it is now recognized that many of these cases may be due to inherited mutations, mainly in genes coding for sarcomeric proteins. As gene therapy is still in its infancy, more sensitive and specific markers are required for the early detection and monitoring of heart failure development in the clinical setting. The continuous innovations in proteomic technologies will help pinpoint protein posttranslational modifications that could underlie the transition to heart failure. This link between biology and technology could greatly assist in identifying biomarkers with increased specificity as well as more effective therapies.

With an expanding “toolbox” of comprehensive basic, medical, surgical, and technological approaches, it is expected that these novel findings will soon be translated to the clinical practice. In fact, new therapeutic strategies are desperately needed by the millions of patients suffering from heart failure.

We invite investigators to contribute original research articles as well as review articles regarding new approaches and future trends in the management of heart failure.

Potential topics include, but are not limited to:

  • Genomic, proteomics, and metabolomics of heart failure
  • New biomarkers for early diagnosis and follow-up
  • Clinical experiences on new drugs for the medical therapy
  • New surgical alternatives to transplantation
  • New systems or new materials available for future cardiac assist devices
  • Stem cell therapy

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 278163
  • - Editorial

Alternatives to Transplantation in the Treatment of Heart Failure: New Diagnostic and Therapeutic Insights

Francesco Nicolini | Massimo F. Piepoli | ... | Giuseppe Siniscalchi
  • Special Issue
  • - Volume 2015
  • - Article ID 763940
  • - Research Article

Renal Doppler Resistive Index as a Marker of Oxygen Supply and Demand Mismatch in Postoperative Cardiac Surgery Patients

Francesco Corradi | Claudia Brusasco | ... | Antonella Vezzani
  • Special Issue
  • - Volume 2015
  • - Article ID 265260
  • - Review Article

New Insights in the Diagnosis and Treatment of Heart Failure

Giulio Agnetti | Massimo F. Piepoli | ... | Francesco Nicolini
  • Special Issue
  • - Volume 2015
  • - Article ID 849571
  • - Review Article

Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future

Jatin Anand | Steve K. Singh | ... | Hari R. Mallidi
  • Special Issue
  • - Volume 2015
  • - Article ID 138148
  • - Review Article

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs

Marilisa Molinaro | Pietro Ameri | ... | Carlo G. Tocchetti
  • Special Issue
  • - Volume 2015
  • - Article ID 898373
  • - Research Article

Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs

Paloma Morillas-Sendín | Emilio Delgado-Baeza | ... | Begoña Quintana-Villamandos
  • Special Issue
  • - Volume 2015
  • - Article ID 257848
  • - Research Article

Design and Evaluation of a Fully Implantable Control Unit for Blood Pumps

Kristin Unthan | Felix Gräf | ... | Ulrich Steinseifer
  • Special Issue
  • - Volume 2015
  • - Article ID 929170
  • - Review Article

Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases

Ayodeji Adegunsoye | Matthew Levy | Olusegun Oyenuga
  • Special Issue
  • - Volume 2015
  • - Article ID 691693
  • - Research Article

Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters

Aderville Cabassi | Simone Maurizio Binno | ... | Enrico Fiaccadori
  • Special Issue
  • - Volume 2015
  • - Article ID 590851
  • - Clinical Study

Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis

Margarita Kunin | Vered Carmon | ... | Dganit Dinour
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit